Amanda Steffon, LCSW | |
333 W 1425 N, Cedar City, UT 84721-8872 | |
(435) 267-1700 | |
Not Available |
Full Name | Amanda Steffon |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 333 W 1425 N, Cedar City, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154172757 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 7748904-3501 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Amanda Steffon, LCSW 5948 W Juniper Acres Ct, West Valley, UT 84128-4609 Ph: () - | Amanda Steffon, LCSW 333 W 1425 N, Cedar City, UT 84721-8872 Ph: (435) 267-1700 |
News Archive
Keeping radiation dose in check is a top safety concern for today's hospitals, particularly in computed tomography, which has undergone some significant technological advances in the last ten years. The down side is that CT delivers some of the highest radiation doses in diagnostic radiology.
Depressed individuals with a tendency to ruminate on negative thoughts, i.e. to repeatedly think about particular negative thoughts or memories, show different patterns of brain network activation compared to healthy individuals, report scientists of a new study in Biological Psychiatry.
Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has obtained a non-exclusive license to incorporate the BRAF V600E mutation sequence into Asuragen's molecular diagnostic products. The license was obtained from Johns Hopkins University and includes the use of the BRAF V600E mutation as a component of diagnostic test kits and for use in Asuragen's CLIA laboratory for clinical research and patient testing.
Oncolytics Biotech has announced that subsequent to the regulatory review period for this submission, it is proceeding with a Phase II trial to evaluate the intravenous administration of REOLYSIN in patients with various sarcomas that have metastasized to the lung.
Gamida Cell announced today that the Gamida Cell-Teva Joint Venture has received an FDA Fast Track Designation for StemEx, in development as an alternative to a bone marrow transplant for patients with blood cancers such as leukemia and lymphoma.
› Verified 9 days ago
Carol Marie Rowley, LCSW, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 158 Monterey Dr, Cedar City, UT 84720 Phone: 608-658-8368 | |
Mr. Brent Hinton Judd, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 775 S 1175 W, Cedar City, UT 84720 Phone: 435-586-0535 Fax: 435-586-4914 | |
Nateasa Lynn Mcguire, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2202 N Main St Ste 301, Cedar City, UT 84721 Phone: 319-541-4485 | |
Julee Loces, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2069 N Main St Ste 101, Cedar City, UT 84721 Phone: 435-267-4212 | |
Mr. Delynn T Lamb, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6484 N 2300 W, Cedar City, UT 84721 Phone: 435-867-4876 | |
Mr. Tyson Bruce Terry, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2202 N Main St Ste 301, Cedar City, UT 84720 Phone: 435-586-4479 | |
Kevin Scott Kirschenmann, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 245 E 680 S, Cedar City, UT 84720 Phone: 435-867-7654 Fax: 435-867-7699 |